arcus biosciences stock price

Wedbush decreased their target price on shares of Arcus Biosciences from 4200 to 3600 and set an outperform rating for the company in a report on Thursday. A high-level overview of Arcus Biosciences Inc.

Black Rhino Wheels On Instagram 20 Chamber Tvecustomjeeps Erikmarroquin Blackrhinowheels Jeepwrangler Jlu

Get the latest Arcus Biosciences Inc RCUS detailed stock quotes stock data Real-Time ECN charts stats and.

. A popular way to gauge a stocks volatility is its beta. Arcus Biosciences has a 1 year low of 1674 and a 1 year high of 4910. Learn more on RCUSs analyst rating.

Compare RCUS Stock to Peers. SVB Securities Adjusts Arcus Biosciences Price Target to 49 from 66 Keeps Outperform Rating. Announced that the Compensation Committee of the Companys Board of Directors granted six new employees options to purchase a total of 10200 shares of the Companys common stock at an exercise price per share of 2619 which was the closing price on July 25 2022 and restricted stock units to acquire a total of.

NYSE AT CLOSE 400 PM EDT 062422. Δ 1 Yr. The stock was sold at an.

Arcus Biosciences Inc. RCUS delivered earnings and revenue surprises of 0 and 2742 respectively for the quarter ended June 2022. Arcus Biosciences Inc.

For the fiscal year ended 31 December 2021 Arcus Biosciences Inc revenues increased from 775M to 3829M. Net income totaled 528M vs. In other Arcus Biosciences news President Juan C.

AFTER HOURS 517 PM EDT 062422. Wedbush Adjusts Price Target on Arcus Biosciences to 36 From 42 Keeps Outperform Rating. NYSERCUS opened at 2872 on Friday.

Δ 5 Yr. Get the latest Arcus Biosciences Inc RCUS real-time quote historical performance charts and other financial information to help you make more informed trading and investment decisions. Stock analysis for Arcus Biosciences Inc RCUSNew York including stock price stock chart company news key statistics fundamentals and company profile.

According to the issued ratings of 7 analysts in the last year the consensus rating for Arcus Biosciences stock is Buy based on the current 7 buy ratings for RCUS. View Arcus Biosciences Inc RCUS investment stock information. Revenues reflect License revenue segment increase from 551M to 3438M Collaboration revenue segment increase of 69 to 379M.

The sustainability of the stocks immediate price movement based on the recently-released numbers and future earnings. Arcus Biosciences Inc etfs funds price quote with latest real-time prices charts financials latest news technical analysis and opinions. Over the last 12 months Arcus Biosciencess shares have ranged in value from as little as 1674 up to 491.

About Arcus Biosciences Inc. The stock was sold at an average price of 2072. Beta is a measure of a shares volatility in relation to the market.

Jaen sold 2333 shares of the businesss stock in a transaction dated Thursday June 16th. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools. 3928 POINT EDEN WAY HAYWARD California 94545 United States 1 510 694-6200.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. Get Arcus Biosciences Inc RCUSNYSE real-time stock quotes news price and financial information from CNBC. Goldman Sachs Adjusts Arcus Biosciences Price Target to 29 From 28 Maintains Neutral Rating.

The average twelve-month price prediction for Arcus Biosciences is 4875 with a high price target of 6000 and a low price target of 3600. The sustainability of the stocks immediate price.

Pin Page